Navigation Links
Ebola virus disarmed by excising a single gene
Date:1/21/2008

MADISON - The deadly Ebola virus, an emerging public health concern in Africa and a potential biological weapon, ranks among the most feared of exotic pathogens.

Due to its virulent nature, and because no vaccines or treatments are available, scientists studying the agent have had to work under the most stringent biocontainment protocols, limiting research to a few highly specialized labs and hampering the ability of scientists to develop countermeasures.

Now, however, a team of researchers from the University of Wisconsin-Madison has figured out a way to genetically disarm the virus, effectively confining it to a set of specialized cells and making the agent safe to study under conditions far less stringent than those currently imposed.

"We wanted to make biologically contained Ebola virus," explains Yoshihiro Kawaoka, a professor of pathobiological sciences in the UW-Madison School of Veterinary Medicine and the senior author of a paper describing the system for containing the virus published today (Jan. 21, 2008) in the Proceedings of the National Academy of Sciences. "This is a great system."

The Ebola virus first emerged in 1976 with outbreaks in Sudan and Zaire. There are several strains of the virus, which causes hemorrhagic fever and during outbreaks kills anywhere from 50-90 percent of its human victims.

At present, research on live Ebola virus is confined to the very highest level of biosafety, known as Biosafety Level 4 (BSL 4). Because such laboratories are rare, small and very expensive, basic research that is the basis for any potential drugs or vaccines to thwart the virus has been limited to perhaps half a dozen labs worldwide. The system devised by Kawaoka and his colleagues could provide a way to greatly expand studies of the pathogen and speed the development of countermeasures.

Taming Ebola virus, according to the new study, depends on a single gene known as VP30. Like most viruses, Ebo
'/>"/>

Contact: Yoshihiro Kawaoka
kawaokay@svm.vetmed.wisc.edu
608-265-4925
University of Wisconsin-Madison
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Features of replication suggest viruses have common themes, vulnerabilities
2. First all-African GM crop is resistant to maize streak virus
3. Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
4. Gamma globulin effective in treating eye infections caused by adenoviruses
5. Discovery may help defang viruses
6. Who will recover spontaneously from hepatitis C virus infection
7. Prions and retroviruses -- an unholy alliance?
8. Scientists learn structure of enzyme in unusual virus
9. UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC
10. New field-deployable biosensor detects avian influenza virus in minutes instead of days
11. Depression, aging, and proteins made by a virus may all play role in heart disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., police officers and ambulance workers faced a te...omplex. They battled to save people from the colla... fires and evacuated as many people as they could ...ple. And making their jobs even harder was the pro...d their relatives jammed mobile networks with call...
(Date:11/25/2009)...istant professors recently received funding from t...esearch beneficial to understanding the environmen...r Blackwood, assistant professor in the Department...port two separate research projects. , His first...munities and Functions from the Leaf to the Landsc...
(Date:11/24/2009)... doors to understanding how sounds associated with...ammal or if they hear it at all. , The same typ...SA uses to detect flaws in the space shuttle,s beh...s to peek inside the giant head of a whale. The sc...cas of a whale,s hearing anatomy using a breakthro...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 1Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 2Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 3Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 4Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 5Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 6Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 7Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 1Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 3A study to prevent sudden death in sports by means of genetic testing 59151 1A study to prevent sudden death in sports by means of genetic testing 59151 2
...k about house calls! The Wildlife Conservation Soc...ad To Early Detection" campaign for their assistan...Bronx Zoo. , The on-site procedureperformed by d...edical personnel from several institutionswas made...8-foot-long MRI facility on wheels that conducted ...
...IS, CALIF.A new drug developed at the University o...n and inflammatory has entered Phase II of human c...ompound, a soluble epoxide hydrolase enzyme (s-EH)...eat a suite of major cardiovascular and metabolic ...th UC Berkeley cell biologist Sarjeet Gill discove...
...emarkable new invention from Tel Aviv University ...led "Smart Dew" will foil even the most determine...sts and doorways, or indoors on the floor of a ban...ctive system for safeguarding and securing wide sw...Tel Aviv University Faculty of Engineering team dr...
Other Biology News:Gorilla gets MRI at Bronx Zoo 2Gorilla gets MRI at Bronx Zoo 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 2UC Davis bench-to-bedside research: Promising treatment in clinical trials 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 4UC Davis bench-to-bedside research: Promising treatment in clinical trials 5Intruder alert: Tel Aviv University's 'Smart Dew' will find you! 2
(Date:11/24/2009)... This release is available in German . , ...ation cards: RFID tags (Radio Frequency Identifica...yday life. They make it possible to label objects ...frequency. The appropriate scanner can read and pr...s can be affixed to goods under production conditi...
(Date:11/24/2009)..., , CALGARY and BLENHEIM, Ontario, Nov. 24... announced today it is acquiring the assets of Hyl...heim, Ontario. The addition of Hyland Seeds will f...ness as the company anticipates the introduction o... Herbicide Tolerant Trait Technology in corn in 20...
(Date:11/24/2009)..., , SHANGHAI, Nov. 24 /PRNewswire-A...Patent & Trademark Office (PTO) has allowed th...livery or NOD technology. , NOD technolog...ptides or,proteins into bio-adhesive nano-particle...istered as injections. NOD technology is a platfor...
(Date:11/24/2009)..., , , Primary efficacy endpoint has be...urrent endometrial cancer, , QUEBEC CITY, Nov.... (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a gl...e therapy and oncology, today announced positive e...d cytotoxic peptide conjugate, AEZS-108 (formerly ...
Breaking Biology Technology:Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...on Area Technical College would like to see more ... ,Over the last decade, the percentage of women in... to 32 percent, said Janet Kelly, communications d... in IT programs has dropped to under 20 percent. ,...e on Wednesday was Patricia Prime, chief informati...
...d Imaxio S.A. (Saint-Beauzire, France) have fina...ide rights to manufacture and sell OverExpress b...der the agreement, Imaxio will retain the right to...al applications, but Lucigen will provide the cell...ired for research use of OverExpress cells by non-...
.... In addition to being big business (untold billio...us ethical issues and choices. We are all aware of...nsent underlying all clinical trials. , ,What is...carries with it the responsibility to obtain and s...ve or even if the clinical trial is a failure. It ...
Other Biology Technology:MATC seeks to turn around falling tech enrollment among women 2Lucigen Corp. enters global licensing agreement 2What patients want: A story of choice, clinical trials & evidence-based medicine 2What patients want: A story of choice, clinical trials & evidence-based medicine 3What patients want: A story of choice, clinical trials & evidence-based medicine 4What patients want: A story of choice, clinical trials & evidence-based medicine 5
Bovine TNP-BGG (Bovine Gamma Globulin), BGG (Bovine Gamma Globulin) conjugated/tagged from Biosearch Technologies
Equine TNF-alpha (TNFSF1A) ELISA development Kit, DuoSet from R&D Systems
Creatinine Colorimetric Assay Kit from R&D Systems
Equine IL-4 from AbD Serotec
Biology Products: